According to the latest report by IMARC Group, titled “Gene Synthesis Market Report by Method (Solid-Phase Synthesis, Chip-Based Synthesis, PCR-Based Enzyme Synthesis), Services (Antibody DNA Synthesis, Viral DNA Synthesis, and Others), Application (Gene and Cell Therapy Development, Vaccine Development, Disease Diagnosis, and Others), End Use (Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Contract Research Organizations), and Region 2025-2033,” the global gene synthesis market size reached USD 2.4 Billion in 2024. Gene synthesis refers to the laboratory method used to create a deoxyribonucleic acid (DNA) sequence. It involves the artificial construction of a specific sequence of nucleotides as compared to the extraction of naturally occurring DNA. It allows for exact control over the sequence, which enables researchers to create genes without any unwanted mutations. It is commonly used to study gene function, produce proteins, or engineer organisms with new capabilities.
Global Gene Synthesis Market Trends:
The increasing preference for personalized medicines and new generation drugs and formulations on account of the surging prevalence of chronic and lifestyle disorders, such as cancer, diabetes, and Alzheimer’s, represents one of the major factors driving the need for gene synthesis around the world. Moreover, the rising geriatric population, which is susceptible to such ailments, is augmenting the market growth. In addition, the growing number of clinical trials by pharmaceutical companies and extensive improvements in medical infrastructure and diagnostic technologies are influencing the market positively. Apart from this, gene synthesis finds application in the agricultural sector to enable the development of crops with desired traits like drought resistance or enhanced nutritional value. This, coupled with the increasing farming activities and rising adoption of organic farming practices, is strengthening the growth of the market. Looking forward, the market value is projected to reach USD 9.6 Billion by 2033, expanding at a CAGR of 15.75% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Methods Covered | Solid-Phase Synthesis, Chip-Based Synthesis, PCR-Based Enzyme Synthesis |
Services Covered | Antibody DNA Synthesis, Viral DNA Synthesis, Others |
Applications Covered | Gene and Cell Therapy Development, Vaccine Development, Disease Diagnosis, Others |
End Uses Covered | Biotechnology and Pharmaceutical Companies, Academic and Government Research Institutes, Contract Research Organizations |
Regions Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | ATUM, Boster Biological Technology, Eurofins Genomics, Genewiz Inc. (Azenta Life Sciences), Genscript Biotech Corp., Integrated DNA Technologies Inc., Merck KGaA, OriGene Technologies Inc., ProMab Biotechnologies Inc., ProteoGenix Inc, Thermo Fisher Scientific Inc., Twist Bioscience, etc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Group
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Americas:- +1 631 791 1145 | Africa and Europe :- +44-753-713-2163 | Asia: +91-120-433-0800